Alternatived Products of [ 20866-48-2 ]
Product Details of [ 20866-48-2 ]
CAS No. : 20866-48-2
MDL No. : MFCD00038856
Formula :
C19 H27 NO7
Boiling Point :
-
Linear Structure Formula : -
InChI Key : MRYIHKCPPKHOPJ-AWEZNQCLSA-N
M.W :
381.42
Pubchem ID : 7010630
Synonyms :
Calculated chemistry of [ 20866-48-2 ]
Physicochemical Properties
Num. heavy atoms :
27
Num. arom. heavy atoms :
6
Fraction Csp3 :
0.53
Num. rotatable bonds :
11
Num. H-bond acceptors :
7.0
Num. H-bond donors :
2.0
Molar Refractivity :
98.77
TPSA :
111.16 Ų
Pharmacokinetics
GI absorption :
High
BBB permeant :
No
P-gp substrate :
Yes
CYP1A2 inhibitor :
No
CYP2C19 inhibitor :
Yes
CYP2C9 inhibitor :
Yes
CYP2D6 inhibitor :
No
CYP3A4 inhibitor :
No
Log Kp (skin permeation) :
-5.64 cm/s
Lipophilicity
Log Po/w (iLOGP) :
3.04
Log Po/w (XLOGP3) :
4.2
Log Po/w (WLOGP) :
3.52
Log Po/w (MLOGP) :
2.19
Log Po/w (SILICOS-IT) :
2.2
Consensus Log Po/w :
3.03
Druglikeness
Lipinski :
0.0
Ghose :
None
Veber :
1.0
Egan :
0.0
Muegge :
0.0
Bioavailability Score :
0.56
Water Solubility
Log S (ESOL) :
-4.29
Solubility :
0.0196 mg/ml ; 0.0000514 mol/l
Class :
Moderately soluble
Log S (Ali) :
-6.24
Solubility :
0.000218 mg/ml ; 0.00000057 mol/l
Class :
Poorly soluble
Log S (SILICOS-IT) :
-3.75
Solubility :
0.0674 mg/ml ; 0.000177 mol/l
Class :
Soluble
Medicinal Chemistry
PAINS :
0.0 alert
Brenk :
2.0 alert
Leadlikeness :
3.0
Synthetic accessibility :
3.53
Safety of [ 20866-48-2 ]
Signal Word: Warning
Class: N/A
Precautionary Statements: P261
UN#: N/A
Hazard Statements: H302-H315-H319-H335
Packing Group: N/A
GHS Pictogram:
Application In Synthesis of [ 20866-48-2 ]
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Downstream synthetic route of [ 20866-48-2 ]
1
[ 20866-48-2 ]
[ 35661-40-6 ]
[ 71989-14-5 ]
[ 125238-99-5 ]
[ 110116-75-1 ]
2
[ 20866-48-2 ]
[ 35661-40-6 ]
[ 71989-14-5 ]
(R)-N5 -(tert.-butoxy-carbonyl)-N2 -(9-fluorenylmethoxycarbonyl)-ornithine
[ No CAS ]
[ 106818-61-5 ]
3
[ 20866-48-2 ]
[ 71989-14-5 ]
[ 77128-73-5 ]
(R)-N5 -(tert.-butoxy-carbonyl)-N2 -(9-fluorenylmethoxycarbonyl)-ornithine
[ No CAS ]
[ 106327-80-4 ]
4
[ 20866-48-2 ]
[ 71989-14-5 ]
[ 132684-59-4 ]
(R)-N5 -(tert.-butoxy-carbonyl)-N2 -(9-fluorenylmethoxycarbonyl)-ornithine
[ No CAS ]
[ 110116-74-0 ]
5
[ 20866-48-2 ]
[ 71989-14-5 ]
[ 95753-55-2 ]
(R)-N5 -(tert.-butoxy-carbonyl)-N2 -(9-fluorenylmethoxycarbonyl)-ornithine
[ No CAS ]
[ 106327-79-1 ]
6
[ 20866-48-2 ]
[ 71989-14-5 ]
[ 102410-65-1 ]
(R)-N5 -(tert.-butoxy-carbonyl)-N2 -(9-fluorenylmethoxycarbonyl)-ornithine
[ No CAS ]
[ 110116-73-9 ]
7
[ 20866-48-2 ]
[ 67605-64-5 ]
Carbonic acid 4-{(S)-2-tert-butoxycarbonylamino-2-[4-((1Z,4Z,9Z,15Z)-10,15,20-triphenyl-porphyrin-5-yl)-phenylcarbamoyl]-ethyl}-phenyl ester tert-butyl ester
[ No CAS ]
8
[ 13734-34-4 ]
[ 20866-48-2 ]
[ 5241-66-7 ]
[ 35899-43-5 ]
Boc-Leu-OH, Boc-Met-OH, Boc-Asp(benzyl)-OH
[ No CAS ]
[ 119975-64-3 ]
9
[ 3744-87-4 ]
[ 7536-58-5 ]
[ 71066-00-7 ]
[ 20866-48-2 ]
Boc-Val-OH, Boc-Gly-OH
[ No CAS ]
[ 143293-95-2 ]
10
[ 13734-34-4 ]
[ 2419-94-5 ]
[ 20866-48-2 ]
[ 115186-31-7 ]
Boc-Val-OH, Boc-Gly-OH
[ No CAS ]
[ 143294-01-3 ]
11
[ 3744-87-4 ]
[ 7536-58-5 ]
[ 20866-48-2 ]
[ 151838-62-9 ]
Boc-Val-OH, Boc-Gly-OH
[ No CAS ]
[ 143293-97-4 ]
12
[ 7536-58-5 ]
[ 13734-34-4 ]
[ 20866-48-2 ]
[ 151838-62-9 ]
Boc-Val-OH, Boc-Gly-OH
[ No CAS ]
[ 143293-98-5 ]
13
[ 7536-58-5 ]
[ 13734-34-4 ]
[ 20866-48-2 ]
[ 115186-31-7 ]
Boc-Val-OH, Boc-Glu-OH
[ No CAS ]
[ 143294-04-6 ]
14
[ 13734-34-4 ]
[ 20866-48-2 ]
[ 55674-63-0 ]
[ 35899-43-5 ]
Boc-Leu-OH, Boc-Nle-OH, Boc-Asp(benzyl)-OH
[ No CAS ]
[ 143294-05-7 ]
15
[ 13139-15-6 ]
[ 13734-34-4 ]
[ 20866-48-2 ]
[ 151838-62-9 ]
Boc-Nle-OH, Boc-Asp-OH
[ No CAS ]
[ 143293-99-6 ]
16
[ 20866-48-2 ]
[ 137460-59-4 ]
2-<i>tert</i>-butoxycarbonylamino-3-(4-<i>tert</i>-butoxycarbonyloxy-phenyl)-propionic acid 4-oxo-3-phenoxy-2-trifluoromethyl-4<i>H</i>-chromen-7-yl ester
[ No CAS ]
Yield Reaction Conditions Operation in experiment
71%
Stage #1: (S)-2-(tert-butoxycarbonylamino)-3-(4-(tert-butoxycarbonyloxy)phenyl)propanoic acid With dicyclohexyl-carbodiimide In tetrahydrofuran at 0℃; for 1h;
Stage #2: 2-trifluoromethyl-3-phenoxy-7-hydroxychromone With dmap In tetrahydrofuran at 0℃;
17
[ 42381-05-5 ]
[ 20866-48-2 ]
[ 895167-06-3 ]
18
[ 20866-48-2 ]
[ 6240-01-3 ]
[ 895167-08-5 ]
19
[ 20866-48-2 ]
[ 75667-94-6 ]
[ 895167-11-0 ]
20
[ 20866-48-2 ]
[ 3395-35-5 ]
Boc-Tyr(Boc)-DL-3,4-ΔPro-OH
[ No CAS ]
Yield Reaction Conditions Operation in experiment
99%
Stage #1: (S)-2-(tert-butoxycarbonylamino)-3-(4-(tert-butoxycarbonyloxy)phenyl)propanoic acid With pivaloyl chloride; triethylamine In acetonitrile at -20℃; for 0.333333h;
Stage #2: DL-3,4-Dehydroproline In acetonitrile at -20 - -10℃; for 1.33333h; Further stages.;